Artículos del autor

solaci

Day 1

LEADERS FREE ACS: Biolimus coated stent vs. bare metal stent in ACS with high bleeding risk

Original Title: Biolimus A9 drug-coated stent vs. bare metal stent in patients presenting with ACS. A pre-specified...
solaci -
Day 1

FANTOM II: New sirolimus eluting bioresorbable scaffold

Original Title: Fantom sirolimus-eluting BRS – FANTOM II Trial. Presenter: Alexandre Abizaid   This new sirolimus eluting bioresorbable scaffold is...
solaci -
Day 1

EWOLUTION: Outcomes of left atrial appendage closure in the real world

Original Title: EWOLUTION: 3-months outcome of Left Atrial Appendage Closure with the WATCHMAN device in Europe. Presenter: Martin...
solaci -
Institutional News

SOLACI@EuroPCR: Management of STEMI in Latin America and Europe

Yesterday, May 17th, took place the SOLACI Session @EuroPCR about management of STEMI in Latin America and...
solaci -
Femoropopliteal

Zilver PTX: Maintains efficacy in real life most challenging lesions?

Original Title: Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan...
solaci -
Infrapatellar

Drug coated balloons: Superior in infrapopliteal territory?

Original Title: Drug-Coated Balloons for Revascularization of Infrapopliteal Arteries. A Meta-Analysis of Randomized Trials. Reference: Salvatore Cassese et...
solaci -
EuroPCR 2016

EuroPCR 2016

All the news about this International Congress. From 17th to 20th of May - Palais des Congrès, Paris,...
solaci -
Chronic Ischemic cardiopathy

LV: Everolimus Eluting Stents vs. Coronary Artery Bypass Graft

Original Title: Revascularization in Patients with Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus...
solaci -